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Abstract 
Background: Abnormalities of the placenta affects 5-7% of pregnancies. Since disturbances in fetal 
growth are often preceded by dysfunction of the placenta and/ or attenuation of its normal expansion, 
placental health warrants careful surveillance. Currently, there is limited normative data available for 
placental volume by magnetic resonance imaging (MRI). 
Objective: To determine normative ranges of placental volume by MRI throughout gestation. 
Materials and Methods: In this cross-sectional retrospective analysis, MRI examinations of pregnant 
females obtained between 2002 and 2017 at a single institution were reviewed. Semi-automated 
segmentation of the placenta was performed in images obtained on patients with no radiologic evidence 
of maternal or fetal pathology, using Philips Intellispace Tumor Tracking Tool.  
Results: Placental segmentation was performed in 112 women and had a high degree of interrater 
reliability (single measure intraclass correlation coefficient = 0.978 with 95% CI 0.956, 0.989; p<0.001). 
Normative data on placental volume by MRI increased nonlinearly from 6 and 39 weeks gestation, with 
wider variability of placental volume at higher gestational age (GA). Placental volumetric data was fit to a 
polynomial curve of third order described as placental volume = -0.02*GA3 + 1.6*GA2 - 13.3*GA + 8.3. 
Placental volume showed positive correlation with estimated fetal weight (p=0.03) and birth weight 
(p=0.05).  
Conclusion: This study provides normative placental volume by MRI from early first trimester to term 
gestation. Deviations in placental volume from normal may prove to be an imaging biomarker of adverse 
fetal health and neonatal outcome and further studies are needed to more fully understand this metric. 
Assessment of placental volume should be considered in all routine fetal MRI examinations.  
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Introduction 
Abnormalities of the placenta affects 5-7% of pregnancies [1, 2]. Evidence is accumulating that 
the placenta is directly responsible for both the immediate and long-term health of the fetus [3, 4]. Fetal 
growth is the primary indicator of overall fetal health, and birth weight is strongly linked to infant 
survival [5]. Since disturbances in fetal growth are often preceded by dysfunction of the placenta and/or 
attenuation of its normal expansion [6], placental growth and development warrant careful surveillance. 
Normal placental imaging demonstrates increasing size and heterogeneity as gestation progresses (Fig. 1), 
but this progression does not always occur. Imaging studies that can identify predictors of impending fetal 
growth disruption should be a major focus of efforts to improve fetal and neonatal health outcomes. 
Abnormal placental volume may prove to be an imaging biomarker of an adverse fetal environment and 
provide an opportunity for intervention before fetal health is compromised.   
Evaluation of the placenta is part of routine antenatal ultrasound (US), but the lack of soft tissue 
contrast and narrow field of view can limit this technique. Furthermore, depending on placental location 
within the uterus, US may be limited by its ability to penetrate tissues. When fetal growth becomes 
compromised, umbilical artery Doppler US studies are frequently used to assess fetal blood supply and 
provide an indirect assessment of the placenta. Noncontrast MR imaging has become more accessible and 
useful for more detailed evaluation in the setting of fetal anomalies, but currently, little to no quantitative 
information about the placenta is obtained from these studies. One contributor to our limited 
understanding of abnormal placental growth is the lack of established normative data, particularly normal 
ranges for placental volume by MRI. In 2001, Duncan, et al. published the first large scale study of fetal 
organ volume and placental volume throughout gestation using echo-planar MRI at 0.5 Tesla [7]. In 2016, 
those ranges were updated in a study of placental growth by MRI at 1.5 Tesla in the second and third 
trimesters in a longitudinal cohort of 20 healthy pregnant women [8]. However, little is known about 
placental volume in the first trimester or if this small sample size accurately represents population norms, 
as no larger studies have replicated these findings to date.  
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The objective of our study was to determine placental volume by MRI from early first trimester to 
term gestation. We used semi-automated segmentation of the placenta to create normative ranges of 
placental volume by MRI throughout gestation in a radiologically normal cohort of pregnant women.  
 
Material and Methods 
Study Participants 
The Institutional Review Board of our academic health care system approved this retrospective 
cross-sectional imaging study with waiver of participant consent. The institutional radiology database was 
queried for MR imaging of pregnant females between 2002 and 2017 and images were categorized by 
diagnosis. Imaging was performed for a variety of clinical indications including concern for fetal 
pathology, suspected invasive placenta, or concern for maternal intra-abdominal inflammatory process. 
Imaging studies with any radiologic evidence of maternal or fetal pathology, as determined by the clinical 
radiology report and chart review, were excluded from analysis. Any immediate maternal or fetal 
postnatal abnormality documented in the chart was assessed for its impact on the placental size; studies 
with intrapartum documentation of placenta accreta were excluded from analysis. Imaging studies with 
multiple gestation were excluded from analysis, as well as imaging studies on fetuses who were later 
found to have pathology later in pregnancy or at birth. Studies from pregnancies resulting in a neonate 
with birthweight below the 3rd percentile or above the 97th percentile for GA were also excluded.  
Maternal clinical and demographic information was obtained by retrospective chart review, 
including age, height, weight, BMI, gestational age (GA), parity, race, health conditions (specifically 
tobacco use, hypertension, and diabetes) and medications used during pregnancy. Gestational age was 
determined by either first trimester US or last menstrual period. In patients for whom GA information was 
not available in the maternal medical record, MRI measures of the fetal biparietal diameter, 
anteroposterior cerebral dimension, anteroposterior pons, transverse cerebellar dimension, overall brain 
maturation, and femur length were compared to published normative data to determine GA at time of 
MRI [9]. Clinical information about the fetus was obtained by chart review and included fetal sex, 
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estimated fetal weight percentile by US obtain within 30 days of MRI; and for those infants that were 
later born within our medical system, GA at delivery, and growth parameters at birth including weight, 
length and occipito-frontal circumference.  
MRI Studies 
Imaging studies were obtained on a Siemens 1.5 tesla scanner between years 2002 and 2013 
(MAGNETOM Avanto-Fit; Siemens, Erlangen, Germany) and on a Siemens 3.0 tesla scanner between 
2014 and 2017 (MAGNETOM Skyra; Siemens, Erlangen, Germany). Exact pulse sequences differed 
depending on the indication for MRI but placental segmentation was performed using either the half-
Fourier acquisition single-shot fast spin-echo (SSFSE) sequence or the balanced steady-state free 
precession (SSFP) gradient echo sequence. All scans utilized for placental segmentation included three 
planes of imaging.  
Image Analysis 
Magnetic resonance studies, prior to segmentation, were reviewed to ensure adequate quality of 
placental imaging and those with inadequate visualization of the placenta (partially outside field of view, 
low resolution, or motion artifact) were excluded from analysis (n=43). Semi-automated placental 
segmentation was performed on images in the maternal axial plane, which frequently (but not uniformly) 
corresponded to the placental axial plane. We found that this plane allowed for clearest demarcation of 
placental margins (Fig. 2). Segmentation was performed by a single observer (R.L.L., physician in 
fellowship) using Philips Intellispace ® software Tumor Tracking Tool (Koninklijke Philips N.V., 
Amsterdam, Netherlands). Although propagation of the region of interest (ROI) with edge detection 
occurred automatically through the image series, manual adjustment of the ROI was performed in each 
slice of the selected sequence to ensure accuracy. Volume of the ROI was calculated based on slice 
thickness by the software and recorded for analysis. A subset of images of the study population were 
measured by a second observer (B.P.B., pediatric radiologist, 5 years post-fellowship experience) to 
assess interrater reliability.  
Statistical Analysis 
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 Statistical analysis was performed using SPSS Statistics 24 (IBM, Armonk, New York, USA). 
Placental volume data was fit to a polynomial curve of third order and differences from expected 
placental volume based on the equation of the best-fit curve were calculated for each patient 
measurement. Correlation of the nonparametric placental volume data with continuous, nominal or 
ordinal dependent variables was determined by the Spearman’s rho, Mann-Whitney U, or Kruskal-Wallis 
tests, respectively. Intraclass correlation coefficient (ICC) using a two-way random model to measure 
absolute agreement was calculated to determine interrater reliability on a subset of the total population 
analyzed [10]. For all analyses, the level of significance was set at p < 0.05.  
 
Results 
Study Population 
A total of 1,010 abdominal or fetal MR imaging studies of pregnant women were performed at 
our institution between 2002 and 2017 for concern for maternal or fetal pathology. There was a total of 
848 studies excluded from analysis due to positive finding of radiologic abnormality in mother or fetus, 
leaving 155 studies (16%) with no maternal or fetal radiologic abnormality. A total of 43 studies were 
excluded due to inadequate placental imaging, an additional 4 studies were excluded due to multiple 
gestation, and 3 studies were excluded due to neonatal birthweight <3rd percentile or greater than 97th 
percentile (Fig. 3). Placental segmentation was performed on a total of 112 MRI. Gestational age at time 
of MRI ranged from 6 to 39 weeks. There were seven MRI studies for which GA was not available and 
was determined by fetal biometry. Maternal age ranged from 16 to 45 years with an average age of 26 
years. Of the included women, 25% were primiparous, 42% were multiparous, 18% were grand-
multiparous (gravida 5 or more) and 15% had no available information on parity. The clinical indication 
for MRI was divided nearly equally between maternal (48%) and fetal concerns (46%). An additional 6% 
of MR imaging examinations came from healthy volunteers recruited in a prior investigation (Table 1). 
The majority of maternal indication for MRI were right lower quadrant pain with no abnormality on 
imaging and the majority of the fetal indications were concern for absent cavum septum pellucidum 
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ultimately found to have normal anatomy on MRI. Neonatal characteristics were available for 60% of the 
study population. Neonates delivered on average at 38 2/7 weeks gestation and weighed an average of 
3,181 grams at birth.  
Placental Volume 
Between six and nine weeks gestation the mean placental volume was 10.1 mL, which increased 
to a mean of 1,039 mL by term (Table 2). The equation that best described the placental volume increase 
throughout gestation in this population (R² = 0.75) is reported below, where GA is expressed in weeks 
(Fig. 4): 
Placental volume = -0.02*GA3 + 1.6*GA2 - 13.3*GA + 8.3 
A high degree of interrater reliability was found between the subset of placental volume 
measurements representing 30% of the total population studied, with an average measure ICC of 0.978 
(95% CI = 0.956, 0.989; p<0.001). No subjective difference in placental volume or ability to discern 
placental margins was noted between imaging studies at 1.5 versus 3.0 Tesla or based on sequence used 
to perform segmentation (SSFP versus SSFSE). Placental location within the uterus was recorded, with 
most placentae located anteriorly (47%), followed by 38% in posterior position, and 5% located laterally. 
Inferiorly located placentas in this cohort were exclusively observed in women in the first trimester of 
pregnancy and any imaging with the finding of placenta previa beyond the first trimester was deemed 
abnormal and excluded from analysis.  
Spearman’s rho test for this nonparametric data set demonstrated no correlation between 
placental volume and maternal pre-pregnancy weight, height, BMI, or age (Table 3). There was a positive 
correlation between estimated fetal weight and placental volume (ρ=0.378, n=32, p=0.03). Birth weight 
percentile had a similar positive association with placental volume (ρ=0.249, n=61, p=0.05). In the few 
cases of maternal hypertension (n=12) in our data set, no statistically significant differences in placental 
volume were measured (p=0.90). Similarly, for those with maternal diabetes mellitus (n=8), no 
correlation with placental volume was found (p=0.90). Information on maternal medications and level of 
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control of these conditions were not available. Tobacco use was documented in the medical chart of 27 
women in the study, but no information on amount or duration was recorded, and there was no significant 
association with placental volume (p=0.11).  
 
Discussion 
The present study provides normative placental volume by MRI measured as early as 6 weeks 
gestation and as late as 39 weeks gestation in 112 women whose imaging studies showed no fetal or 
maternal radiologic abnormalities. We found a nonlinear relationship between placental volume and GA 
with increasing variability in placental volume at higher gestational ages. A large portion of our sample 
data represent the time when most women would be referred for fetal MRI in response to concerns on US 
in the mid-second trimester. Our results add to the placental volume data reported in recent MRI placental 
segmentation studies with smaller cohorts [8, 11, 12].  
In the prospective study by Langhoff, et al., the authors provide longitudinal placental volume in 
seven repeated MRI scans from second trimester to term gestation in a cohort of 20 healthy, primiparous 
women using no medications and with body mass index of 18 to 30 [8]. This data set has the advantage of 
excluding women with complicating conditions that likely affect placental volume. Langhoff et al. also 
performed placental segmentation seven times on each participant, providing information on interval 
placental growth. Our placental volume data are significantly higher, particularly at higher GA compared 
to Langhoff et al., slightly lower than those reported by Duncan et al.[7], and very close to those 
described by Andescavage et al. [11]. For example, placental volume at term gestation is approximately 
1,250 mL in the report by Duncan et al., compared to our volume of 1,039 mL between 37 and 40 weeks, 
approximately 1,000 mL at term by Andescavage et al., and 787 mL between 37 and 39 weeks in the 
report by Langhoff et al. These variations can likely be attributed to differences in populations studied, 
imaging equipment, segmentation tools, and technical experience. Both our patient population and the one 
described by Duncan et al. include a large number of multiparous women, which has been shown in 
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previous studies to be associated with larger volume of the delivered placenta [13]. In addition, Duncan et 
al. obtained images with 0.5 Tesla MRI, which likely affected resolution and complicated determination 
of the placental plane at the basal plate [7]. At both 1.5 and 3.0 Tesla magnetic strengths, we found that 
placental contrast with amniotic fluid at the chorionic plate was easily visualized in all sequences, but the 
demarcation of the basal plate was slightly more difficult to discern in our earlier studies at lower 
magnetic field. We observed that these tissue planes are equally discernible on both SSFSE and SSFP 
sequences. 
There were also differences in segmentation software used in each of these studies. Andescavage 
et al. utilized ITK-SNAP, while Langhoff et al. measured placental volume with a segmentation tool by 
Circle Cardiovascular Imaging, Inc. Our use of the Philips Intellispace Tumor Tracking Tool for 
segmentation analysis allows our results to be comparable to those obtainable by most radiologists who 
evaluate fetal MR imaging. This tool allows users to reproducibly measure the placenta in multiple places 
of MR imaging sequences. Although the Tumor Tracking Tool was created for the purposes of repeated 
measures of tumors to determine response to chemotherapy, this segmentation tool demonstrated 
excellent precision with only 0.1 – 0.6 cm3 discrepancy in tumor volume by imaging compared with 
excised hepatic tumor size in rabbits [14]. In addition, our interrater reliability statistics demonstrate a 
high degree of reproducibility of placental volume measurements by this method.  
Alternative methods of placental volumetric analysis have been reported previously with US 
imaging comprising the majority of these studies. New US technologies have been developed to render 
three-dimensional organ reconstructions and have proven useful in assessing placental shape, but have 
limitations in volumetric analysis. Namely, the low soft tissue contrast limits the ability to clearly discern 
the tissue plane that creates the interface between uterus and basal plate of the placenta. Likewise, the 
narrow field of view of US limits full visualization of the placenta, forcing software and technician to 
piecemeal together imaging of the complete organ. Placental volumetric analysis by US, therefore, has 
had varying degrees of success [15-24] with some reports showing low levels of intra- and interrater 
reliability [17, 24, 25]. Volumetric analysis of the placenta by US is most concordant with MRI 
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measurements in the first trimester [16, 18, 23] as later US measurements significantly underestimate 
placental volume. Placental volumes from term pregnancies reported in some studies are significantly less 
than the delivered, partially exsanguinated placenta [15, 19], underscoring the fact that US is not the ideal 
imaging technique for placental volume beyond the first trimester. Compared to one of the largest US 
placental volumetric analyses reports [15], our data correlate well in the first half of pregnancy, but show 
increasingly larger discrepancies beyond the second trimester. Although this US study has the benefit of 
including 423 patient measurements, it is limited by the fact that most placental volume measures were 
obtained at 12 and 20 weeks gestation, thus relying heavily on extrapolation to determine the remainder 
of the placental growth curve.  
With US readily available in most obstetric practices and significantly more cost-effective than 
MRI, it is well-suited as a screening examination for abnormalities of the placenta. In our retrospective 
cohort, only 16% of patients referred for fetal MRI due to concerns for maternal or fetal abnormalities 
over the 15-years of this study, were found to be radiologically normal, demonstrating the high specificity 
of prenatal US in identifying fetal anomalies. Increasing evidence suggests that MRI provides reliable 
additional data useful for prognostication, treatment planning, and even guidance for intrauterine 
intervention, for those select cases where it is indicated. Its utility has been particularly well-established 
for evaluation of fetal intracranial anomalies. Accordingly, the number of referrals for fetal MRI are 
steadily increasing at our institution.  
Despite the advantages of MRI to study the intrauterine environment, there are limitations to 
studies, such as the one presented here. Our data is limited by its observational nature. Each patient in our 
study was referred for MRI for a specific maternal or fetal concern, demonstrating a potential selection 
bias in our population, although only imaging without radiologic abnormalities was included in our 
analysis. In addition, our study population reflects the demographics of our location with few non-
Caucasian women and a high number of overweight and obese women in this cohort, although no 
correlation was found between placental volume and weight or BMI. As with all retrospective studies, we 
cannot draw conclusions on the causative relationships between placental volume and clinical factors 
Placental Volume by MRI - Page 10 of 18 
 
analyzed here. Information on maternal hypertension, diabetes, and tobacco use was collected by medical 
chart review, but was only available for 82% of subjects, and there were no data collected on whether 
medical management of these conditions was successful. Likewise, fetal outcome and growth parameters 
at birth were unknown for a large portion of our study participants, as many women who underwent MRI 
received the remainder of their obstetric care outside our hospital system. These limitations highlight the 
need for future investigations of placental volume in larger, prospective cohorts in a more diverse study 
population. Future studies, should not, however, be limited to primiparous women or only those with 
normal BMI, as this does not accurately reflect population norms. Future investigations may also examine 
changes in placental signal intensity compared to an internal control, such as muscle, to determine 
whether this may be predictive of placental abnormalities. In addition, studies of placental volume in 
patients with maternal and fetal pathology will also be necessary to clarify how this metric can best be 
used to identify fetuses at risk of impaired placental growth. 
A key question raised by this study is the physiologic relevance of placental volume; specifically, 
how placental volume relates to placental function in vivo. We do not yet know whether a larger placenta 
uniformly enhances blood flow to the fetus, or whether in some cases, placental growth may be 
deleterious to fetal health. The case of the morbidly adherent placenta poses a particularly uncertain 
clinical scenario. With Cesarean section rates (the greatest risk factor for morbidly adherent placenta) 
climbing [26], studies suggest that we should expect increasing incidence of morbidly adherent placenta. 
Understanding the hemodynamic effects of the invasive placenta will be paramount to the obstetric 
management of these patients. Advanced MRI analysis techniques evaluating placental function, such as 
intravoxel incoherent motion (IVIM) of diffusion-weighted imaging have promising application to 
placental imaging research, specifically in elucidating the hemodynamic consequences of abnormal 
placental volume [27-30].  
Alterations of placental structure and function in cases of fetal pathology are also poorly 
understood. In fetuses with congenital heart disease, placental growth as compared to birthweight 
percentile is larger than in healthy fetuses [11]. This may be interpreted as placental compensation for the 
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structurally abnormal heart and subsequent disruption of normal blood flow patterns resulting in 
decreased oxygen delivery to target organs. In fetal gastroschisis, we know that placental microstructure 
is altered, with evidence of vascular hyperplasia or chorangiosis reported within the terminal chorionic 
villi of delivered placentas from these patients [31]. Chorangiosis is thought to arise in states of chronic 
low-level hypoxemia, as encountered with gestation at high altitude [32]. Coupled with the high rate of 
intrauterine growth restriction in cases of gastroschisis, the conclusion arises that this placental 
remodeling is likely associated with an attempted compensation of the organ. How this structural change 
at the microscopic level translates into a functional compensation of the placenta in vivo remains 
unknown. Abnormalities of the placenta in other forms of fetal pathology are less well defined. Since the 
placenta is almost entirely of fetal origin, there is good reason to postulate that aberrations in placental 
structure and/or function may exist concomitant with other forms of fetal pathology. 
In addition, many studies exist establishing the effects of maternal exposures on placental growth 
and subsequent effects on the fetus. Perhaps the best studied of these is maternal smoking, which has well 
known deleterious effects on placental and fetal growth [33] and imparts significantly elevated risk of 
both fetal and early neonatal mortality [34]. Pathologic characteristics of the placenta exposed to maternal 
smoking include decreased placental vascularization, thickening of the villous and trophoblast 
membranes, and higher rates of syncytiotrophoblastic necrosis [35]. Using MR imaging, Anblagan, et al. 
demonstrated that maternal smoking is associated with smaller fetal organ size including reduced brain 
and placenta volume [33]. Contrast-enhanced MR imaging studies in non-human primates have shown 
that nicotine exposure alone also adversely affects placental hemodynamics [36]. Similar studies 
demonstrating in vivo functional effects of maternal smoking on the placenta in humans have not yet been 
reported. Maternal diabetes is also a well-defined fetal exposure with adverse effects. It leads most often 
to increased placental volume and surface area at birth but with villous immaturity [37]. As in maternal 
smoking, the in vivo characterization of dysglycemia on the placenta is uncertain. The use of advanced 
MR imaging techniques may be the key to understanding the pathophysiology of these and other specific 
exposures on  
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placental structure and function. 
 
Conclusion 
This study provides normative placental volume ranges by MRI from early first trimester to term 
gestation. Future studies are indicated to determine normative placental volume in larger and more 
diverse populations in order to further refine this metric, which may prove to be an imaging biomarker of 
fetal and neonatal health outcomes. Assessment of placental volume should be considered in all routine 
fetal MRI examinations.  
 
Ethical Approval 
All procedures performed in studies involving human participants were in accordance with the ethical 
standards of the institutional and/or national research committee and the 1964 Helsinki declaration and its 
later amendments or comparable ethical standards. For this type of retrospective study, formal consent is 
not required. 
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Table 1. Patient Characteristics. 
Total MRI Analyzed 112 
GA in weeks at MRI, mean (range) 25 6/7  (6 0/7 - 
39 3/7) 
Maternal age in years, mean (range) 26.7 (16 - 45) 
Parity, n (%) 
 
Primiparous 28  (25) 
Multiparous 47 (42) 
Grand Multiparous (G5+) 20 (18) 
Unknown 17 (15) 
Race or Ethnicity, n (%) 
 
Caucasian 71 (63) 
African-American 24 (21) 
Asian 4 (3) 
Hispanic 1 (<1) 
American-Indian 1 (<1) 
Unknown 11 (10) 
Maternal BMI, n (%)  
Underweight (BMI <18.5) 2 (2) 
Normal weight (BMI 18.5-25) 28 (25) 
Overweight (BMI 25-30) 17 (15) 
Obese (BMI >30) 23 (20) 
Unknown 42 (38) 
Indication for MRI, n (%) 
 
Maternal 50 (48) 
Fetal 55 (47) 
Clinical Study 7 (6)  
GA: gestational age; BMI: body mass index 
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Table 2. Placental volume characterized by gestational age. 
Weeks Gestation (n) Range Placental Volume (mL) 
Mean Placental 
Volume (mL) SD SEM 
6 0/7 to 9 6/7 (3) 8.4 - 11.8 10.1 1.7 1.0 
10 0/7 to 12 6/7 (5) 19 - 44 36.0 9.9 4.4 
13 0/7 to 15 6/7 (5) 21 - 121 69.4 41.7 18.6 
16 0/7 to 18 6/7 (7) 75 - 257 146.2 79.9 39.9 
19 0/7 to 21 6/7 (9) 182 - 355 251.2 66.9 22.3 
22 0/7 to 24 6/7 (18) 199 - 689 367.8 129.5 30.5 
25 0/7 to 27 6/7 (20) 259 - 637 460.8 89.3 20.5 
28 0/7 to 30 6/7 (15) 334 - 1024 561.7 193.6 50.0 
31 0/7 to 33 6/7 (10) 373 - 1145 693.0 193.3 61.1 
34 0/7 to 36 6/7 (17) 432 - 1090 717.9 194.8 47.2 
37 0/7 to 40 6/7 (3) 883 - 1262 1039.3 198.0 114.3 
SD: standard deviation; SEM: standard error of the mean 
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Table 3. Spearman’s ρ correlation with placental volume. 
 n Mean (SD) ρ p-value 
 Maternal Age (years) 112 26.7 (6.2) 0.106 0.27 
 Maternal Weight (kg, pre-pregnancy) 70 74.6 (19.4) 0.118 0.33 
 Maternal Height (cm) 73 164 (7.1) 0.054 0.65 
 Maternal BMI (pre-pregnancy) 70 27.9 (7.6) 0.103 0.40 
 Estimated Fetal Weight Percentile 32 28.9 (25.5) 0.378* 0.03* 
 Birth Weight Percentile 61 47.7 (27.6) 0.249* 0.05* 
 Birth Length Percentile 48 59.8 (27.2) 0.125 0.40 
BMI: body mass index; SD: standard deviation; statistical significance indicated by * for p<0.05.  
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Figure Legends 
Fig. 1: Increasing heterogeneity and complexity of the placenta (*) across gestation in T2 single-shot fast 
spin-echo images in the coronal plane in 35 year old female at 10 weeks and 3 days gestation (A), in the 
axial plane in a 33 year old female at 23 weeks 5 days gestation (B), and in the axial plane in a 25 year 
old female at 37 weeks 6 days gestation (C). 
 
Fig. 2: Placental segmentation using Philips Intellispace Tumor Tracking Tool performed on imaging 
study from 23 year old female at 33 weeks and 5 days gestation.  
 
Fig. 3: Flow chart of study population with description and number of imaging studies excluded from 
analysis. 
 
Fig. 4: Placental volume by gestational age in radiologically normal cohort of 112 pregnant women 
demonstrating nonlinear distribution of placental volume across gestation and increasing variability in 
placental volume at higher gestational ages, with best-fit curve described by the third order polynomial 
equation. 
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